U.S. Capital Wealth Advisors LLC lowered its stake in The Cigna Group (NYSE:CI – Free Report) by 53.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,383 shares of the health services provider’s stock after selling 7,381 shares during the period. U.S. Capital Wealth Advisors LLC’s holdings in The Cigna Group were worth $1,763,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. ORG Wealth Partners LLC bought a new stake in shares of The Cigna Group during the fourth quarter worth about $34,000. Ulland Investment Advisors LLC increased its position in shares of The Cigna Group by 2,500.0% during the third quarter. Ulland Investment Advisors LLC now owns 104 shares of the health services provider’s stock worth $36,000 after acquiring an additional 100 shares in the last quarter. Prospera Private Wealth LLC bought a new stake in shares of The Cigna Group during the third quarter worth about $37,000. Harbor Capital Advisors Inc. bought a new stake in shares of The Cigna Group during the third quarter worth about $45,000. Finally, Heck Capital Advisors LLC bought a new stake in shares of The Cigna Group during the fourth quarter worth about $53,000. Institutional investors and hedge funds own 86.99% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have issued reports on the stock. UBS Group reduced their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a “buy” rating for the company in a research report on Monday. Truist Financial reduced their target price on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Stephens reduced their target price on shares of The Cigna Group from $410.00 to $380.00 and set an “overweight” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft reduced their target price on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research report on Monday, November 4th. Finally, Piper Sandler reissued an “overweight” rating and set a $348.00 target price (down from $394.00) on shares of The Cigna Group in a research report on Monday. Two analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, The Cigna Group presently has a consensus rating of “Buy” and a consensus price target of $378.00.
The Cigna Group Stock Down 0.6 %
Shares of NYSE:CI opened at $292.56 on Tuesday. The firm has a fifty day moving average price of $294.40 and a two-hundred day moving average price of $324.18. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72. The Cigna Group has a one year low of $262.03 and a one year high of $370.83. The company has a market cap of $81.38 billion, a price-to-earnings ratio of 23.90, a PEG ratio of 0.97 and a beta of 0.54.
The Cigna Group (NYSE:CI – Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The health services provider reported $6.64 earnings per share for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the firm posted $6.79 EPS. Analysts anticipate that The Cigna Group will post 29.66 EPS for the current fiscal year.
The Cigna Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 2.06%. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s dividend payout ratio (DPR) is presently 45.75%.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than The Cigna Group
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- How to Invest in Small Cap Stocks
- What is a Stock Market Index and How Do You Use Them?
- These Are the Dividend Stocks Insiders Bought in January
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- How the ‘No Buy’ Trend of 2025 Is Boosting These 3 Stocks
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.